Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts | Zendy

G. M. Lee | Zendy; Ken Kleinman | Zendy; Stephen I. Pelton | Zendy; WP Hanage | Zendy; Susan S. Huang | Zendy; Matthew Lakoma | Zendy; M. Maya Dutta-Linn | Zendy; Nicholas J. Croucher | Zendy; Abbie E. Stevenson | Zendy; Joel Finkelstein | Zendy

Open Access

Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts

Author(s) -

G. M. Lee,

Ken Kleinman,

Stephen I. Pelton,

WP Hanage,

Susan S. Huang,

Matthew Lakoma,

M. Maya Dutta-Linn,

Nicholas J. Croucher,

Abbie E. Stevenson,

Joel Finkelstein

Publication year - 2013

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pit057

Subject(s) - medicine , carriage , streptococcus pneumoniae , pneumococcal conjugate vaccine , vaccination , pneumococcal infections , pediatrics , virology , microbiology and biotechnology , antibiotics , pathology , biology

In April 2010, a 13-valent pneumococcal conjugate vaccine (PCV13) replaced PCV7 for use in the United States. We evaluated rates of pneumococcal colonization, by serotype and antibiotic resistance, in Massachusetts communities where serial cross-sectional surveillance has been conducted for the past decade.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research